Status:
ACTIVE_NOT_RECRUITING
REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Type 2 Diabetes (Adult Onset)
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Latino individuals, the fastest growing ethnic minority population in the United States, have a higher prevalence of type 2 diabetes and diabetes-related complications, and are more likely to report i...
Detailed Description
Latino adults have a disproportionate burden of type 2 diabetes and diabetes-related complications. Diabetes medication non-adherence is an important modifiable contributor to suboptimal glycemic mana...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus
- Have current or prior (since 2018) HbA1c ≥8.0%
- Take at least one diabetes medication
- Receive care at MGH- affiliated primary care practices (≥2 visits in the past 3 years)
- ≥18 yrs
- Identify as Latino and/or Hispanic
- Speak and read in Spanish as preferred language
- Willing and able to provide informed consent
- Access to a mobile telephone with text messaging capability
- Suboptimal diabetes medication adherence, assessed using the first 2 items in the Adherence to Refill and Medication Scale (ARMS-d) questionnaire combined: "How frequently do you forget or decide to not take your diabetes medications?" Participants who answer sometimes, almost always, and/or always will be considered eligible for the study.
Exclusion
- Auditory limitations and/or inability to communicate orally
- Inability to receive, read, or send a text message (assessed by a trained research assistant)
Key Trial Info
Start Date :
June 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06000813
Start Date
June 18 2024
End Date
February 28 2027
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Diabetes Research Center
Boston, Massachusetts, United States, 02114